Meta-Analysis Reveals Safety Concerns With FDA-Approved Dual Orexin Receptor Antagonists for Insomnia Neurology Live, 11 Mar 2024 A meta-analysis on studies assessing FDA-approved dual orexin receptor antagonists for insomnia treatment highlighted a greater…